Chiron Real Estate has recently released its 10-K report for the year ended December 31, 2025. The company, a net-lease medical REIT, acquires healthcare facilities and leases them to physician groups and regional and national healthcare systems.
In the report, Chiron Real Estate reported total revenue of $148.2 million for the year ended December 31, 2025, compared to $138.8 million for the same period in 2024, representing an increase of $9.4 million. The increase was primarily attributed to the net impact of acquisitions and dispositions during 2024 and 2025. Rental revenue for 2025 was $147.7 million, up from $138.4 million in 2024, while other income rose from $370,000 in 2024 to $526,000 in 2025.
The company's general and administrative expenses for the year ended December 31, 2025 were $20.0 million, down from $21.1 million for the same period in 2024. Operating expenses for 2025 were $32.6 million, compared to $29.3 million in 2024. Depreciation expense for 2025 was $44.0 million, up from $40.4 million in 2024, while amortization expense increased from $14.9 million in 2024 to $15.0 million in 2025. Interest expense for 2025 was $31.8 million, compared to $28.7 million in 2024.
Chiron Real Estate reported a net loss of $6.9 million for the year ended December 31, 2025, a significant decrease from the net income of $6.7 million for the same period in 2024. The company's principal assets consisted of investments in real estate, net, of $1.2 billion as of December 31, 2025.
In terms of cash flow, the company reported net cash provided by operating activities of $73.6 million for the year ended December 31, 2025, compared to $70.0 million for the same period in 2024. Net cash used in investing activities for 2025 was $60.4 million, up from $45.9 million in 2024, while net cash used in financing activities for 2025 was $10.3 million, down from $21.9 million in 2024.
Chiron Real Estate also provided non-GAAP financial measures, including Funds from Operations (FFO), Core Funds from Operations (Core FFO), and Funds Available for Distribution (FAD). For the year ended December 31, 2025, FFO attributable to common stockholders and noncontrolling interest was $57.6 million, while Core FFO was $65.8 million, and FAD was $52.4 million.
These figures reflect Chiron Real Estate's financial performance and position for the year, showcasing both the company's growth and the challenges it faced in 2025. The market has reacted to these announcements by moving the company's shares 0.11% to a price of $36.11. For more information, read the company's full 10-K submission here.
